Nevada 2023 Regular Session

Nevada Senate Bill SCR5 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
	1	+
	2	+	(Reprinted with amendments adopted on May 24, 2023)
	3	+	FIRST REPRINT S.C.R. 5
	4	+
	5	+	- SCR5_R1
	6	+
	7	+	SENATE CONCURRENT RESOLUTION NO. 5–SENATOR LANGE
	8	+
	9	+	MAY 11, 2023
	10	+	____________
	11	+
	12	+	Referred to Committee on Health and Human Services
	13	+
	14	+	SUMMARY—Urges the expansion of comprehensive
	15	+	cardiovascular screening programs and directs the
	16	+	Joint Interim Standing Committee on Health and
	17	+	Human Services to conduct a study concerning such
	18	+	programs and certain other matters relating to
	19	+	cardiovascular disease. (BDR R-1025)
	20	+
	21	+	~
	22	+
	23	+	EXPLANATION – Matter in bolded italics is new; matter between brackets [omitted material] is material to be omitted.
1	24
2	25
3		-	- 82nd Session (2023)
4		-	Senate Concurrent Resolution No. 5–Senator Lange
5		-
6		-	FILE NUMBER..........
7	26		SENATE CONCURRENT RESOLUTION—Urging the expansion
8	27		of comprehensive cardiovascular screening programs and
9	28		directing the Joint Interim Standing Committee on Health
10	29		and Human Services to conduct a study concerning such
11		-	programs and certain other matters relating to cardiovascular
12		-	disease.
13		-	WHEREAS, The Centers for Disease Control and Prevention of
14		-	the United States Department of Health and Human Services has
15		-	stated that cardiovascular disease is the leading cause of death in the
16		-	United States; and
17		-	WHEREAS, According to the Centers for Disease Control and
18		-	Prevention, approximately 20.1 million people have been diagnosed
19		-	with atherosclerotic cardiovascular disease and are at risk of a
20		-	cardiovascular event; and
21		-	WHEREAS, The Mayo Clinic has stated that atherosclerotic
22		-	cardiovascular disease is linked to cholesterol accumulating in the
23		-	arteries and the risk of associated cardiovascular events may be
24		-	reduced by lowering low-density lipoprotein cholesterol; and
25		-	WHEREAS, According to a report from the American Heart
26		-	Association, in 2016, nearly 68 million adults in the United States
27		-	had a high level of low-density lipoprotein cholesterol; and
28		-	WHEREAS, The Centers for Disease Control and Prevention has
29		-	reported that 47 million people in the United States are currently
30		-	receiving medication to lower their level of low-density lipoprotein
31		-	cholesterol and thereby manage their risk of a cardiovascular event;
32		-	and
33		-	WHEREAS, Data from the National Health and Nutrition
34		-	Examination Survey in 2011-2012 provides that only approximately
35		-	20 percent of people with atherosclerotic cardiovascular disease
36		-	who are taking statins, a leading therapy to lower low-density
37		-	lipoprotein cholesterol, are successfully reducing their level of low-
38		-	density lipoprotein cholesterol to a healthy level; and
39		-	WHEREAS, According to the American Heart Association, the
40		-	total direct and indirect cost of atherosclerotic cardiovascular
41		-	disease in the United States was $555 billion in 2016 and is
42		-	projected to reach $1.1 trillion by 2035; and
43		-	WHEREAS, The Centers for Disease Control and Prevention has
44		-	stated that health care professionals in Nevada have diagnosed 8
45		-	percent of adults in this State with a symptom of atherosclerotic
	30	+	programs and certain other matters relating to
	31	+	cardiovascular disease.
	32	+	WHEREAS, The Centers for Disease Control and Prevention of 1
	33	+	the United States Department of Health and Human Services has 2
	34	+	stated that cardiovascular disease is the leading cause of death in the 3
	35	+	United States; and 4
	36	+	WHEREAS, According to the Centers for Disease Control and 5
	37	+	Prevention, approximately 20.1 million people have been diagnosed 6
	38	+	with atherosclerotic cardiovascular disease and are at risk of a 7
	39	+	cardiovascular event; and 8
	40	+	WHEREAS, The Mayo Clinic has stated that atherosclerotic 9
	41	+	cardiovascular disease is linked to cholesterol accumulating in the 10
	42	+	arteries and the risk of associated cardiovascular events may be 11
	43	+	reduced by lowering low-density lipoprotein cholesterol; and 12
	44	+	WHEREAS, According to a report from the American Heart 13
	45	+	Association, in 2016, nearly 68 million adults in the United States 14
	46	+	had a high level of low-density lipoprotein cholesterol; and 15
	47	+	WHEREAS, The Centers for Disease Control and Prevention has 16
	48	+	reported that 47 million people in the United States are currently 17
	49	+	receiving medication to lower their level of low-density lipoprotein 18
46	50		– 2 –
47	51
48	52
49		-	- 82nd Session (2023)
50		-	cardiovascular disease, including, without limitation, an angina,
51		-	stroke, heart attack or coronary heart disease; now, therefore, be it
52		-	RESOLVED BY THE SENATE OF THE STATE OF NEVADA, THE
53		-	ASSEMBLY CONCURRING, That the members of the 82nd Session of
54		-	the Nevada Legislature urge state agencies to expand
55		-	comprehensive cardiovascular screening programs to allow for
56		-	earlier identification of patients at risk of cardiovascular events; and
57		-	be it further
58		-	RESOLVED, That the members of the 82nd Session of the
59		-	Nevada Legislature urge state agencies to explore ways to
60		-	collaborate with federal agencies and national organizations to
61		-	establish or expand comprehensive cardiovascular screening
62		-	programs; and be it further
63		-	RESOLVED, That the members of the 82nd Session of the
64		-	Nevada Legislature urge state agencies to evaluate programs to
65		-	improve cardiovascular health which are operating in this State for
66		-	the purpose of accelerating improvements in the care rendered to
67		-	patients at risk of cardiovascular events such that improvements in
68		-	screening, treatment, monitoring and health outcomes are achieved;
69		-	and be it further
70		-	RESOLVED, That the members of the 82nd Session of the
71		-	Nevada Legislature urge the development of policies to reduce the
72		-	number of Americans who die as a result of atherosclerotic
73		-	cardiovascular disease; and be it further
74		-	RESOLVED, That the members of the 82nd Session of the
75		-	Nevada Legislature direct the Joint Interim Standing Committee on
76		-	Health and Human Services to conduct a study during the
77		-	2023-2024 interim concerning cardiovascular screening programs
78		-	that are currently operating in this State, ways for state agencies to
79		-	collaborate with federal agencies and private organizations in the
80		-	evaluation and expansion of such programs and other matters
81		-	relating to cardiovascular disease; and be it further
82		-	RESOLVED, That the study must include a review of the Get
83		-	With The Guidelines program of the American Heart Association,
84		-	the degree to which the program has been adopted by health
85		-	facilities in this State and the success of the program where adopted
86		-	by health facilities in this State; and be it further
87		-	RESOLVED, That the study must consider the provision of
88		-	reimbursement under the Medicaid program for the remote
89		-	monitoring of cardiovascular health; and be it further
90		-	RESOLVED, That the study must include a review of the
91		-	implementation of Complete Streets Programs pursuant to NRS
92		-	403.575 and the identification of gaps in reforms to zoning laws in
	53	+	- SCR5_R1
	54	+	cholesterol and thereby manage their risk of a cardiovascular event; 1
	55	+	and 2
	56	+	WHEREAS, Data from the National Health and Nutrition 3
	57	+	Examination Survey in 2011-2012 provides that only approximately 4
	58	+	20 percent of people with atherosclerotic cardiovascular disease 5
	59	+	who are taking statins, a leading therapy to lower low-density 6
	60	+	lipoprotein cholesterol, are successfully reducing their level of low-7
	61	+	density lipoprotein cholesterol to a healthy level; and 8
	62	+	WHEREAS, According to the American Heart Association, the 9
	63	+	total direct and indirect cost of atherosclerotic cardiovascular 10
	64	+	disease in the United States was $555 billion in 2016 and is 11
	65	+	projected to reach $1.1 trillion by 2035; and 12
	66	+	WHEREAS, The Centers for Disease Control and Prevention has 13
	67	+	stated that health care professionals in Nevada have diagnosed 8 14
	68	+	percent of adults in this State with a symptom of atherosclerotic 15
	69	+	cardiovascular disease, including, without limitation, an angina, 16
	70	+	stroke, heart attack or coronary heart disease; now, therefore, be it 17
	71	+	RESOLVED BY THE SENATE OF THE STATE OF NEVADA, THE 18
	72	+	ASSEMBLY CONCURRING, That the members of the 82nd Session of 19
	73	+	the Nevada Legislature urge state agencies to expand 20
	74	+	comprehensive cardiovascular screening programs to allow for 21
	75	+	earlier identification of patients at risk of cardiovascular events; and 22
	76	+	be it further 23
	77	+	RESOLVED, That the members of the 82nd Session of the 24
	78	+	Nevada Legislature urge state agencies to explore ways to 25
	79	+	collaborate with federal agencies and national organizations to 26
	80	+	establish or expand comprehensive cardiovascular screening 27
	81	+	programs; and be it further 28
	82	+	RESOLVED, That the members of the 82nd Session of the 29
	83	+	Nevada Legislature urge state agencies to evaluate programs to 30
	84	+	improve cardiovascular health which are operating in this State for 31
	85	+	the purpose of accelerating improvements in the care rendered to 32
	86	+	patients at risk of cardiovascular events such that improvements in 33
	87	+	screening, treatment, monitoring and health outcomes are achieved; 34
	88	+	and be it further 35
	89	+	RESOLVED, That the members of the 82nd Session of the 36
	90	+	Nevada Legislature urge the development of policies to reduce the 37
	91	+	number of Americans who die as a result of atherosclerotic 38
	92	+	cardiovascular disease; and be it further 39
	93	+	RESOLVED, That the members of the 82nd Session of the 40
	94	+	Nevada Legislature direct the Joint Interim Standing Committee on 41
	95	+	Health and Human Services to conduct a study during the 42
	96	+	2023-2024 interim concerning cardiovascular screening programs 43
	97	+	that are currently operating in this State, ways for state agencies to 44
	98	+	collaborate with federal agencies and private organizations in the 45
93	99		– 3 –
94	100
95	101
96		-	- 82nd Session (2023)
97		-	order to promote zoning that is more conducive to good
98		-	cardiovascular health; and be it further
99		-	RESOLVED, That, pursuant to subsection 4 of NRS 218E.330,
100		-	the Committee shall submit a report of the study and any
101		-	recommendations for legislation to the Director of the Legislative
102		-	Counsel Bureau for transmittal to the 83rd Session of the Nevada
103		-	Legislature; and be it further
104		-	RESOLVED, That the Secretary of the Senate prepare and
105		-	transmit a copy of this resolution to the President of the United
106		-	States, the Vice President of the United States, members of the
107		-	United States House of Representatives and United States Senate
108		-	and other federal and state government officials and agencies as
109		-	appropriate; and be it further
110		-	RESOLVED, That this resolution becomes effective upon
111		-	adoption.
	102	+	- SCR5_R1
	103	+	evaluation and expansion of such programs and other matters 1
	104	+	relating to cardiovascular disease; and be it further 2
	105	+	RESOLVED, That the study must include a review of the Get 3
	106	+	With The Guidelines program of the American Heart Association, 4
	107	+	the degree to which the program has been adopted by health 5
	108	+	facilities in this State and the success of the program where adopted 6
	109	+	by health facilities in this State; and be it further 7
	110	+	RESOLVED, That the study must consider the provision of 8
	111	+	reimbursement under the Medicaid program for the remote 9
	112	+	monitoring of cardiovascular health; and be it further 10
	113	+	RESOLVED, That the study must include a review of the 11
	114	+	implementation of Complete Streets Programs pursuant to NRS 12
	115	+	403.575 and the identification of gaps in reforms to zoning laws in 13
	116	+	order to promote zoning that is more conducive to good 14
	117	+	cardiovascular health; and be it further 15
	118	+	RESOLVED, That, pursuant to subsection 4 of NRS 218E.330, 16
	119	+	the Committee shall submit a report of the study and any 17
	120	+	recommendations for legislation to the Director of the Legislative 18
	121	+	Counsel Bureau for transmittal to the 83rd Session of the Nevada 19
	122	+	Legislature; and be it further 20
	123	+	RESOLVED, That the Secretary of the Senate prepare and 21
	124	+	transmit a copy of this resolution to the President of the United 22
	125	+	States, the Vice President of the United States, members of the 23
	126	+	United States House of Representatives and United States Senate 24
	127	+	and other federal and state government officials and agencies as 25
	128	+	appropriate; and be it further 26
	129	+	RESOLVED, That this resolution becomes effective upon 27
	130	+	adoption. 28
112	131
113		-	20 ~~~~~ 23
	132	+	H
	133	+
	134	+
114	135